comera_logo_rgb.png
Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option
January 04, 2024 08:30 ET | Comera Life Sciences
WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a proprietary drug-delivery...
comera_logo_rgb.png
Comera Life Sciences Announces Process Exploring Strategic Alternatives
December 06, 2023 08:30 ET | Comera Life Sciences
WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic...
Dorothy Clarke
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
November 13, 2023 08:00 ET | Comera Life Sciences
WOBURN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...
comera_logo_rgb.png
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
November 09, 2023 08:00 ET | Comera Life Sciences
– Final stage of technical evaluation near completion in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Expanded and strengthened Comera’s global patent...
comera_logo_rgb.png
Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference
October 16, 2023 08:00 ET | Comera Life Sciences
WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...
comera_logo_rgb.png
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
September 12, 2023 08:00 ET | Comera Life Sciences
WOBURN, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...
comera_logo_rgb.png
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities
August 16, 2023 08:00 ET | Comera Life Sciences
Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formulations of monoclonal antibodies WOBURN, Mass.,...
comera_logo_rgb.png
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
August 10, 2023 08:00 ET | Comera Life Sciences
– Advanced to final stage of technical evaluation in Comera’s research collaboration with Regeneron, a leading U.S. biotechnology company – – Received notice that Nasdaq granted Comera’s request for...
comera_logo_rgb.png
Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform
August 08, 2023 08:00 ET | Comera Life Sciences
WOBURN, Mass., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...
comera_logo_rgb.png
Comera Life Sciences Announces $4.1 Million Private Placement
August 01, 2023 08:00 ET | Comera Life Sciences
WOBURN, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of biologic medicines to improve patient...